On the Horizon: Asciminib, a New Drug for Treating R/R CML ...Middle East

Medscape - News
A first-in-class STAMP inhibitor, asciminib, shows better efficacy than bosutinib in patients with relapsed/refractory chronic myeloid leukemia in the chronic phase. Medscape Medical News

Hence then, the article about on the horizon asciminib a new drug for treating r r cml was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( On the Horizon: Asciminib, a New Drug for Treating R/R CML )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News